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Abstract  
The effect of intracellular reduced glutathione (GSH) in 
the lead stress response of Saccharomyces cere- visiae was 
investigated. Yeast cells exposed to Pb, for 3 h, lost the 
cell proliferation capacity (viability) and decreased 
intracellular GSH level. The Pb-induced loss of cell via- 
bility was compared among yeast cells deficient in    GSH1 
(Dgsh1) or GSH2 (Dgsh2) genes and wild-type (WT) cells. 
When exposed to Pb, Dgsh1 and Dgsh2 cells did not dis- 
play an increased loss of viability, compared with WT 
cells. However, the depletion of cellular thiols, including 
GSH, by treatment of WT cells with iodoacetamide (an 
alkylating agent, which binds covalently to thiol group), 
increased the loss of viability in Pb-treated cells. In con- 
trast, GSH enrichment, due to the incubation of WT cells 
with amino acids mixture constituting GSH (L-glutamic 
acid, L-cysteine and glycine), reduced the Pb-induced loss 
of proliferation capacity. The obtained results suggest that 
intracellular GSH is involved in the defence against the Pb- 
induced toxicity; however, at physiological   concentration, 
GSH seems not to be sufficient to prevent the Pb-induced 
loss of cell  viability. 
 
 
Introduction 
 
Although lead occurs naturally, its presence in the envi- 
ronment comes, mainly, from human activities, like mining 
or smelting of ore, manufacture of lead-containing products 
(such as car batteries), combustion of coal and oil, and 
waste incineration. Lead is a non-essential metal for bio- 
logical functions and is classified by the International 
Agency for Research on Cancer as probable human car- 
cinogen [1]. 
The yeast Saccharomyces cerevisiae is a suitable 
eukaryotic model organism for studying Pb toxic effects, 
since its cellular structure and functional organization share 
many similarities with animal and plant cells. This yeast 
can be easily manipulated, presents a short generation time 
and has the genome completely sequenced. In addition, 
valuable tools are available such as the yeast deletion strain 
   collection for understanding gene functions  [22]. 
 In S. cerevisiae, Pb inhibits metabolic activity [23] and 
cell growth, impairs ammonium assimilation and reduces 
DNA/RNA ratio [4]. In addition, it was shown that Pb 
induces the intracellular accumulation of reactive oxygen 
species (ROS), which can be the trigger  of programmed 
cell death by apoptosis  [3]. 
Yeast cells have different protection mechanisms for 
controlling the levels of ROS, which can be, basically, 
divided in enzymatic (superoxide dismutases, catalases and 
peroxidases) and non-enzymatic defences (as glutathione 
and trehalose) [10, 12]. 
The   tripeptide   glutathione   (L-c-glutamyl-L-cysteinyl- 
glycine) is the main intracellular low molecular mass thiol. 
  
 
Glutathione is present in cells, principally, as reduced 
form—GSH [15, 17]. GSH is biosynthesized in two 
sequential  steps:  (i)  in  the  first  step,  the  dipeptide  L-c- 
glutamylcysteine is synthesized, from the L-glutamic acid 
and L-cysteine, catalyzed by the enzyme L-c-glutamylcys- 
teine synthetase (GSH1 gene product); and (ii) in the 
second step, glycine is added to the C-terminal of c-glut- 
amylcysteine, by the action of glutathione synthetase 
(GSH2 gene product), to synthesize GSH [7,   17]. 
GSH  play  different  functions  in  yeast  cells  such  as: 
(i) radical scavenger, by reacting directly with radical 
hydroxyl to reduce it to H2O [7]; (ii) electron donor to 
glutathione peroxidases (GPX) and glutaredoxins, which 
catalyzes the reduction of H2O2 and organic peroxides to 
H2O and the corresponding alcohols, respectively [10]. In 
these processes, the GSH is oxidized to glutathione disul- 
phide (GSSG). Glutathione can be reduced back by the 
action of glutathione reductase with the consumption of 
NADPH, which is essential to the maintenance of a high 
reduced–oxidized ratio inside the cell [7,   12]. 
Several works have shown the role of GSH in the pro- 
tection of the cells against the damage provoked by oxi- 
dative stress [11], xenobiotics, carcinogens, radiation [15] 
and heavy metals [Cd, As(III), Sb(III), Se and Hg] [6, 18, 
25]. GSH seems to be a key molecule in the defence 
against oxidative stress and metal toxicity. The involve- 
ment of GSH in metal detoxification can be carried out in 
several ways: (i) binding to metals and subsequent vacuolar 
sequestration; (ii) impairing metal-induced oxidative stress, 
by the mechanisms presented above; and (iii) binding to 
sulphhydryl groups on proteins (protein glutathionylation), 
protecting them from irreversible metal binding and/or 
oxidative damage [25]. However, the role of GSH in Pb 
stress responses, in the yeast S. cerevisiae, is   unknown. 
The present work aims to examine the role of intracel- 
lular GSH in Pb-induced toxicity in S. cerevisiae. For this 
purpose, the loss of viability induced by Pb was evaluated 
in wild-type (WT) and GSH-deficient mutant strains. In 
addition, intracellular GSH content of WT cells was 
modulated by incubation with iodoacetamide (to deplete 
cellular thiols, including GSH) or with the mixture of 
amino acids that make up GSH (GSH-enriched cells); in 
both cases, the influence of the depletion or GSH enrich- 
ment on the modification of the susceptibility of yeast cells 
to Pb was studied. 
 
 
Material and Methods 
 
Strains, Media and Culture  Conditions 
 
Saccharomyces cerevisiae WT yeast strain  BY4741 
(MATa his3D1 leu2D0 met15D0 ura3D0) and the isogenic 
mutants Dgsh1 and Dghs2 were obtained from EURO- 
SCARF collection and used in this  work. 
The strains were routinely maintained at 4 °C on YPD agar 
slants [10 g/l yeast extract (Difco-BD), 20 g/l peptone (Difco- 
BD), 20 g/l glucose (Merck) and 20 g/l agar (Merck)]. 
Mutants were maintained under a selective pressure in YPD 
agar with 0.02 % (w/v) geneticin (Sigma-Aldrich). 
Pre-cultures were prepared in 10 ml of YPD broth in 
100 ml Erlenmeyer flasks. Cells were incubated at 25 °C 
on an orbital shaker, at 150 rpm, for 8–10 h. Cultures in 
exponential growth phase were obtained by  inoculating 
100 ml of YPD broth, in 250 ml Erlenmeyer flasks, with 
pre-cultures and grown overnight (OD600 * 1.0) under the 
same conditions as the  pre-culture. 
 
Treatment of Yeast Cells with  Pb 
 
After growth, cells were harvested by centrifugation 
(2,0009g, 5 min), washed twice with deionized water and 
resuspended   in   2-(N-morpholino)   ethanesulphonic acid 
(MES) pH buffer (Sigma-Aldrich, St. Louis, MO, USA) 
10 mmol/l,   at   pH   6.0,   with   2 %   (w/v)   glucose,    to 
*1 9 107  cells/ml. MES is a suitable pH buffer for heavy 
metal toxicity studies because it does not complex lead [20] 
and yeast cells maintain viability when incubated in this 
buffer for 48 h  [19]. 
Cell suspensions (40 ml) containing 1 9 107 cells/ml, in 
10 mmol/l MES buffer (pH 6.0), with 2 % (w/v) glucose and 
the appropriate volume of lead solution [Pb(NO3)2], from a 
stock standard solution of 2,000 mg/l (Merck) were shaken 
in 100-ml Erlenmeyer flasks at 150 rpm, at 25 °C. Cells were 
treated using a Pb concentration range of 0–1,000 lmol/l in 
order to induce a toxic effect (evaluated by the loss of cell 
proliferation capacity) in wild-type strain of 0–90 %. 
Glutathione Enrichment and Depletion  Assays 
Enrichment of intracellular glutathione content was carried 
out as previously described [11]. Briefly, WT yeast   cells, 
1 9 107 cells/ml, in exponential growth phase, were 
incubated in the dark, with shaking (150 rpm), at 25 °C, for 
1 h, with a mixture containing 0.5 mol/l glucose, 0.01 mol/ 
l MgCl2, 0.02 mol/l L-glutamic acid, 0.02 mol/l  L-cysteine, 
0.02 mol/l glycine and 0.1 mol/l potassium phosphate 
buffer (pH 7.4). In the pre-treatment with cysteine, cells 
were incubated with the mixture described above without 
L-glutamic acid and  glycine. 
For   depletion   of   glutathione,   1 9 107  cells/ml, in 
exponential growth phase, were incubated in the dark, with 
shaking (150 rpm), at 25 °C, for 1 h, with 1 mmol/l 
iodoacetamide (Sigma-Aldrich). 
After the treatment, cells were washed twice with 
deionized water, suspended  in 10 mmol/l  MES  buffer,  at 
  
 
pH 6.0, with 2 % (w/v) glucose and exposed to Pb as 
described above. 
 
Viability Measurement 
 
Viability was determined by plating the cells on YPD agar. 
Thus, samples (1.0 ml; two–three replicates) were taken  at 
defined   intervals   of   time,   serially   diluted   with   sterile 
deionized water and plated (two replicates of 200 ll of the 
convenient  dilutions).  The  colonies  were  counted  after 
3–4 days of incubation at 25 °C. The % of survivors was 
calculated   using   the   number   of   colony-forming   units 
(c.f.u)/ml at zero time as reference (100 %). 
 
Evaluation of Intracellular Reduced Glutathione 
Content 
 
Intracellular GSH was monitored with monochlorobimane 
(mBCl, Sigma-Aldrich)  as previously described [21] with 
minor modifications. After exposition to 1,000 lmol/l Pb, 
for  3 h,  cells  were  washed  once  with  deionized  water, 
suspended   at   1 9 107  cells/ml   in   0.1 mol/l   phosphate 
buffered  saline  solution  (PBS  buffer),  at  pH  7.0,  and 
incubated with mBCl (in a final concentration of 50 lmol/ 
l),  for  2 h,  at  25 °C,  in  the  dark.  Stock  solutions  of 
50 mmol/l  mBCl  were  prepared  in  dimethyl  sulphoxide 
(Sigma-Aldrich) and stored at -20 °C; working solutions 
of  1 mmol/l  were  prepared  in  PBS  buffer,  pH  7.0,  just 
before  use.  Fluorescence  intensity  (as  relative  fluorescent 
units—RFU)  was  measured  using  a  microplate  reader  at 
fluorescence  excitation  of  355/40 nm  and  an  emission  of 
460/25 nm. Fluorescence was normalized (considering cell 
concentration) and corrected by subtracting cell, buffer and 
dye autofluorescence. 
For epifluorescence microscopy analysis, 1 9 107 cells/ 
ml  were  suspended  in 0.1 mol/l  PBS  buffer (pH  7.0)  and 
incubated with mBCl (in a final concentration of 100 lmol/ 
l), for 60 min, at 25 °C, in the dark; cells were examined 
using a Leica DLMB epifluorescence microscope equipped 
with  a  HBO—100  mercury  lamp  and  the  filter  set  A 
[excitation   filter   (band   pass   filter,   BP)   BP   340–380, 
dichromatic mirror 400 and suppression filter (long pass 
filter, LP) LP 425], from Leica. The images were acquired 
with a Leica DC 300F camera using N plan objectives and 
processed using Leica IM 50-Image manager  software. 
 
Reproducibility of the Results 
 
All experiments were repeated, independently, four times. 
Fluorescence data were expressed as the mean ? standard 
deviation (SD), presented with 95 % confidence value, of 
quintuplicate measurements of a typical experiment. The 
data reported for viability were the mean ? SD, presented 
with 95 % confidence value of four independent 
experiments. 
 
 
Results and Discussion 
 
Pb-induced Loss of Viability in Wild-Type 
and Glutathione-Deficient Mutants 
 
The exposition of S. cerevisiae cells to Pb resulted in a 
marked intracellular ROS accumulation [3]. GSH is the 
main redox buffer of the cells being a key factor against the 
oxidative stress and metals toxicity [25]. In this context, the 
effect of reduced GSH on the protection against Pb- 
induced toxicity was evaluated using the WT strain and the 
knockout mutants devoid in the genes GSH1 or GSH2, 
responsible for the enzymes L-c-glutamylcysteine synthe- 
tase and c-glutamylcysteine,  respectively. 
Saccharomyces cerevisiae WT cells, in exponential 
phase of growth, when exposed to different Pb concentra- 
tions, for 3 h, lose the viability, assessed by c.f.u. counting 
on YPD plates, in a dose-dependent manner. The   survival 
of  WT  cells  exposed  to  500  or  1,000 lmol/l  Pb,  for  3 h, 
was 43 or 8 % of cells, respectively (Fig. 1); i.e. these Pb 
concentrations induced a loss of cell proliferation capacity 
of 57 and 92 %,  respectively. 
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Fig. 1 Comparison of the susceptibility to Pb of wild-type and GSH- 
deficient mutant strains of S. cerevisiae. Cells in exponential phase of 
growth of the wild-type strain BY4741 (dark bar) or the isogenic 
GSH-deficient mutant strains Dgsh1 (white bar) and Dgsh2 (grey bar) 
were treated with different Pb concentrations for 3 h. Viability was 
estimated by c.f.u. counts. Each bar represents the mean of four 
independent experiments. Standard  deviations  are  presented  with 
95 % confidence limits (vertical error  bars) 
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Fig. 2 Impact of iodoacetamide or amino acids mixture constituting 
GSH on the viability of Pb-exposed cells of S. cerevisiae. Cells of the 
wild-type strain BY4741, in exponential phase of growth, were 
incubated with 1 mmol/l iodoacetamide (white bar) or with a mixture 
containing  0.5 mol/l  glucose  and  0.02 mol/l  L-glutamate,  L-cysteine       b 12 
and glycine (grey bar), for 1 h, at 25 °C, before being exposed to  Pb, 
for   3 h.   As   control,   cells   of   the   wild-type   strain   BY4741 in 
exponential  phase  of  growth  (non-treated  cells—black  bar)   were 10 
exposed to Pb for 3 h. Viability was estimated by c.f.u. counts.   Each 
bar represents  the mean  of four  independent experiments.  Standard 
deviations are presented with 95 % confidence limits (vertical    error 8 
bars) 
 
Yeast cells lacking GSH1 gene (Dgsh1) are completely 
avoided of GSH; cells lacking GSH2 gene (Dgsh2) are able 
to synthesize L–glutamylcysteine, from L-glutamic acid and 
L-cysteine, but not GSH. The exposition of Dgsh1 or Dgsh2 
mutant strains, to increasing Pb concentrations,  originated 
a marked loss of cell proliferation.  Nevertheless, Dgsh1 
and Dgsh2 strains did not display an increased loss of 
viability compared to WT strain (Fig.  1). 
 
Change in the Thiol Compounds Content Modify 
the Sensitivity to Pb 
 
In order to test if the GSH was not involved as defence 
mechanism or was not present in enough amount to protect 
yeast cells against Pb-induced toxicity, cells from WT 
strain,  in exponential phase  of growth, were treated,    for 
1 h, with 1 mmol/l iodoacetamide (thiol-depleted cells) or 
with an amino acids mixture constituting GSH (GSH- 
enriched cells), washed and subsequently exposed to   Pb. 
Chemical induction of GSH depletion can  be carried 
out, basically, through two mechanisms: (i) reaction with 
GSH, i.e. GSH is depleted due to the reaction with chem- 
icals like diethylmaleate or iodoacetamide; and (ii) by 
inhibition of GSH biosynthesis with an enzyme    inhibitor, 
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Fig. 3  Pb exposition induced the decrease of intracellular glutathione 
content  in  S.  cerevisiae.  Cells  in  exponential  phase  of  growth  were 
incubated  for  3 h  in  the  absence  or  presence  of  1,000 lmol/l  Pb; 
subsequently,  cells  were  washed  and  incubated  with  monochlorobi- 
mane, for 1 h. Untreated cells exhibited fluorescence (due to the 
formation of bimane-glutathione conjugates), which was absent in 
cells exposed to Pb (a). Quantification of fluorescence (b). This is a 
typical  example  of  an  experiment  performed  four  times;  each bar 
represents the mean of five fluorescent readings. Standard deviations 
are presented with 95 % confidence limits (vertical error   bars) 
 
such as L-buthionine sulphoximine [13, 15]. With the aim 
to test the effect of the absence of GSH, on Pb toxicity,  by 
a different way (GSH biosynthesis inhibition was tested 
with Dgsh mutant strains), yeast cells were GSH depleted 
by treatment with iodoacetamide; this compound was 
selected due to its efficiency in GSH depletion, in a short 
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time [16]. The treatment of yeast cells with iodoacetamide 
and subsequent staining with mBCl allowed to verify a 
severe reduction of intracellular thiol content, including 
GSH, as no fluorescence was observed in iodoacetamide- 
treated cells. This observation is in agreement with the 
results presented in the literature which described that the 
treatment with iodoacetamide originates a reduction of  the 
GSH to \5 % of normal levels [16]. On the contrary to 
GSH-deficient mutants, WT cells pre-treated with iodoa- 
cetamide displayed an enhanced sensitivity to Pb compared 
to non-treated cells. The survival of thiol-depleted cells   to 
the exposition to 500 or 1,000 lmol/l Pb, for 3 h, was 10 % 
or \1 %, respectively (Fig. 2). Iodoacetamide is an alkyl- 
ating  agent,  which  binds  covalently  to  thiol  groups [8]. 
Thus, in addition to GSH depletion, iodoacetamide can also 
irreversibly inhibit other thiol compounds and enzymes 
associated with the defence against the oxidative stress; 
these facts can explain the hypersensitivity of iodoaceta- 
mide-treated cells to  Pb. 
The incubation of WT cells with glucose and L-glutamic 
acid, L-cysteine and glycine lead to an increase of  intracel- 
lular   levels  of  GSH  [11].  In  the  presence   of  500  or 
1,000 lmol/l Pb, for 3 h, the GSH-enriched cells presented a 
higher viability, comparatively to non-treated cells (Fig. 2); 
under these conditions, a survival of 78 and 50 %, respec- 
tively, was observed. The pre-treatment of WT cells with 
glucose and L-cysteine did not protect the cells against the 
Pb-induced loss of viability, since a similar % of survival to 
non-treated WT cells was observed. Together, these data 
suggest the involvement of GSH in the defence against the 
Pb-induced toxicity, for instance, as co-factor of enzymatic 
defences against oxidative stress (such as GPX enzymes). 
 
Pb Reduces Intracellular Glutathione  Level 
 
Redox-inactive metals, as is the case of Pb, can produce 
ROS by indirect mechanisms such as the displacement of 
redox-active metals from cellular binding sites, the inhi- 
bition of specific enzymes associated with antioxidant 
defences or by depleting pools of antioxidants, such as 
GSH [2, 25]. 
The intracellular GSH content in S. cerevisiae cells was 
evaluated using mBCl, a cell-permeant probe. Once inside 
the cell, the probe is essentially nonfluorescent until conju- 
gated; mBCl reacts with reduced glutathione and forms 
fluorescent bimane-glutathione (B-SG) adducts [9]. Cells, in 
the absence of Pb, exhibited a typical fluorescence due to the 
formation of B-SG adducts. On the contrary, in   Pb-treated 
cells (1,000 lmol/l Pb, for 3 h) only a faint fluorescence was 
observed (Fig. 3a). As described above, similar images of 
Pb-treated cells were obtained with iodoacetamide-treated 
cells. The quantification of the fluorescent signal produced 
due to the formation of B-SG adducts in cells non-treated or 
treated  with  1,000 lmol/l  Pb,  for  3 h,  showed  a  marked 
reduction  (*94 %)  of  fluorescence  in  Pb-treated  cells 
(Fig. 3b). These results suggested a reduction of intracellular 
GSH in Pb-exposed yeast cells, which is in agreement with 
the data presented in the literature, that describe a GSH 
decrease in kidney, liver and brain cells of rats exposed to 
lead [5, 24]. It is known that several metals including Hg, Cd 
and Pb present high affinity to thiol group [14]. The reduction 
of GSH observed can be due to the affinity of the thiol group 
of GSH to Pb. Once in the cytosol, Pb can be complexed by 
GSH, decreasing the level of GSH. 
 
 
Conclusions 
 
The lack of GSH1 or GSH2 genes did not enhance the 
susceptibility of the yeast cells to the toxic action of Pb. 
However, the manipulation of intracellular GSH content 
modified, markedly, the viability in Pb-exposed cells. In 
addition, the exposition to Pb decreased the intracellular 
GSH level. These results suggest that intracellular GSH is 
involved in the Pb detoxification; however, at physiological 
concentration, GSH seems not enough, per se, to halt the 
Pb-induced loss of cell  viability. 
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